Original articleEfficacy of tofacitinib for the treatment of nail psoriasis: Two 52-week, randomized, controlled phase 3 studies in patients with moderate-to-severe plaque psoriasis
Key words
Abbreviations used
Cited by (0)
This study was sponsored by Pfizer Inc. Medical writing support was provided by Complete Medical Communications and funded by Pfizer Inc.
Conflicts of interest: Dr Merola has received grant/research support from Biogen IDEC; has been an investigator for Amgen, Biogen IDEC, Pfizer Inc, and Regeneron; has acted as a consultant for Biogen IDEC; has participated in advisory boards for AbbVie, Amgen, Eli Lilly, Janssen, Novartis, and Pfizer Inc; and has been involved in speakers' bureaus for AbbVie. Dr Elewski has received research support from Amgen, AbbVie, Boehringer Ingelheim, Celgene, Eli Lilly, Incyte, Merck, Novan, Novartis, Pfizer Inc, Valeant, and Viamet; and has acted as a consultant for Anacor, Celgene, Eli Lilly, Novartis, Pfizer Inc, and Valeant. Drs Tatulych and Tallman and Ms Lan are shareholders and employees of Pfizer Inc. Dr Kaur was a shareholder and employee of Pfizer Inc at the time of the analysis.